Meeting
2021 Genitourinary Cancers Symposium
A phase I clinical trial of PSMA-directed/TGFβ-insensitive CAR-T cells in metastatic castration-resistant prostate cancer.
Authors
Vivek Narayan
University of Pennsylvania, Philadelphia, PA
Vivek Narayan , Julie Barber-Rotenberg , Joseph Fraietta , Wei-Ting Hwang , Simon F. Lacey , Gabriela Plesa , Erica L. Carpenter , Shannon L. Maude , Priti Lal , Neha Vapiwala , Jan J. Melenhorst , Ronnie Sebro , Michael Farwell , Michael Moniak , Joan Gilmore , Lester Lledo , Karen Dengel , Carl H. June , Naomi B. Haas
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session: Prostate Cancer - Advanced Disease
Track
Prostate Cancer - Advanced
Sub Track
Therapeutics
Clinical Trial Registration Number
NCT03089203
Citation
J Clin Oncol 39, 2021 (suppl 6; abstr 125)
DOI
10.1200/JCO.2021.39.6_suppl.125
Abstract #
125
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Genitourinary Cancers Symposium
Safety and early efficacy results from a phase 1, multicenter trial of PSMA-targeted armored CAR T cells in patients with advanced mCRPC.
First Author: Meredith McKean
Poster
2024 ASCO Annual Meeting
Dynamics of circulating cytokines and chemokines during and after tumor-infiltrating lymphocyte cell therapy with lifileucel in advanced melanoma patients.
First Author: Rongsu Qi
Poster
2023 ASCO Genitourinary Cancers Symposium
Phase I results of a phase I/II study of pembrolizumab and AR signaling inhibitor (ARSI) with 225Ac-J591.
First Author: Michael Philip Sun
Poster
2022 ASCO Genitourinary Cancers Symposium
Phase 1 study of P-PSMA-101 CAR-T cells in patients with metastatic castration-resistant prostate cancer (mCRPC).
First Author: Susan F. Slovin